Opioid abuse in the United States and department of health and human services actions to address opioid-drug-related overdoses and deaths

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 29, Issue 2, 2015, Pages 133-139

[No Author Info available]

Author keywords

Abuse; Department of Health and Human Services; Federal response; Issue Brief; Opioid

Indexed keywords

BENZODIAZEPINE; BUPRENORPHINE; CONTROLLED SUBSTANCE; DIAMORPHINE; METHADONE; NALOXONE; OPIATE; PRESCRIPTION DRUG; NARCOTIC ANTAGONIST;

AGE; ALASKA NATIVE; AMERICAN INDIAN; ANALGESIA; ARTICLE; CAUCASIAN; CLINICAL DECISION MAKING; DECISION SUPPORT SYSTEM; DRUG ABUSE; DRUG DEPENDENCE TREATMENT; DRUG FATALITY; DRUG MISUSE; DRUG OVERDOSE; DRUG SURVEILLANCE PROGRAM; ELECTRONIC MEDICAL RECORD; EMERGENCY HEALTH SERVICE; EUROPEAN AMERICAN; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; MEDICAL INFORMATICS; PRACTICE GUIDELINE; PRESCRIPTION; RURAL AREA; SEX DIFFERENCE; UNITED STATES; GOVERNMENT; HEROIN DEPENDENCE; MORTALITY; OPIOID-RELATED DISORDERS; ORGANIZATION AND MANAGEMENT; PRESCRIPTION DRUG MISUSE; STATISTICS AND NUMERICAL DATA;

DRUG OVERDOSE; HEROIN DEPENDENCE; HUMANS; NALOXONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUG MISUSE; UNITED STATES; UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES;

EID: 84932131862     PISSN: 15360288     EISSN: 15360539     Source Type: Journal    
DOI: 10.3109/15360288.2015.1037530     Document Type: Article

References (38)

1. Centers for Disease Control and Prevention. Web-based Injury Statistics Query and Reporting System (WISQARS) [online]. 2014. Retrieved from: http://www.cdc.gov/injury/wisqars/fatal.html.
2. Paulozzi L, Jones C, Mack K, Rudd R; Centers for Disease Control and Prevention (CDC). Vital signs: overdoses of prescription opioid analgesics-United States, 1999-2008. MMWR Morb Mortal Wkly Rep. 2011;60(43):1487-1492.
3. Centers for Disease Control and Prevention/National Center for Health Statistics, National Vital Statistics System, Mortality File. Retrieved from: http://www.cdc.gov/nchs/data/hestat/drug poisoning/drug poisoning.htm.
4. Centers for Disease Control and Prevention. QuickStats: Rates of Deaths from Drug Poisoning and Drug Poisoning Involving Opioid Analgesics-United States, 1999-2013. MMWR Weekly. Retrieved from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6401a10.htm.
5. HedegaardH, Chen LH, Warner M. National Center forHealth Statistics (NCHS). Drug-poisoning deaths involving heroin: States, 2000-2013. NCHS data brief, no190. Retrieved from: http://www.cdc.gov/nchs/data/databriefs/db190.pdf.
6. Food and Drug Administration. Risk Assessment and Risk Mitigation Reviews. Retrieved from: http://www.accessdata. fda.gov/drugsatfda docs/nda/2014/205777Orig1s000RiskR.pdf.
7. Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA. 2013 Feb 20;309(7):657-9
8. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. The DAWN Report: Highlights of the 2011 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits. Retrieved from : http://www.samhsa.gov/data/sites/default/files/DAWN127/DAWN127/sr127-DAWNhighlights. htm.
9. Creanga AA, Sabel JC, Ko JY, Wasserman CR, Shapiro-Medoza CK, Taylor P, Barfield W, et al. Maternal drug use and its effect on neonates:a population-based study in Washington State. Obstet Gynecol. 2012;199(5):924-933.
10. Zibbell JE, Hart-Malloy R, Barry J, Fan L, Flanigan C. Risk factors forHCVinfection among young adults in ruralNew York who inject prescription opioid analgesics. Am J Public Health. 2014 Nov;104(11):2226-32. doi: 10.2105/AJPH.2014.302142. Epub 2014 Sep 11.
11. Mateu-Gelabert P1, Guarino H2, Jessell L2, Teper A2. Injection and sexual HIV/HCV risk behaviors associated with nonmedical use of prescription opioids among young adults in New York City. J Subst Abuse Treat. 2015 Jan;48(1):13-20. doi: 10.1016/j.jsat.2014.07.002. Epub 2014 Jul 11.
12. Rolita L, Spegman A, Tang X, Cronstein BN. Greater number of narcotic analgesic prescriptions for osteoarthritis is associated with falls and fractures in elderly adults. J Am Geriatr Soc. 2013;61(3):335-340.
13. MillerM, Sturmer T, Azrael D, Levin R, Solomon DH. Opioid analgesics and the risk of fractures in older adults with arthritis. J Am Geriatr Soc. 2011;59(3):430-438.
14. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality. Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. Detailed Tables, 7.2B. Retrieved from: http://www.samhsa.gov/data/sites/default/files/NSDUHDetTabs2013/NSDUH-DetTabs2013.htm#tab7.2b.
15. Jones CM. Frequency of prescription pain reliever nonmedical use: 2002-2003 and 2009-2010. Arch Intern Med. 2012;172(16):1265-1267.
16. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. Retrieved from: http://www.samhsa.gov/data/sites/default/files/NSDUHresults PDFWHTML2013/Web/NSDUHresults2013.htm.
17. Jones CM, Paulozzi LJ, Mack KA. Sources of prescription opioid pain relievers by frequency of past-year nonmedical use United States, 2008-2011. JAMA Intern Med. 2014 May;174(5):802-3.
18. Rudd RA, Paulozzi LJ, Bauer MJ, Burleson RW, Carlson RE, Dao D, Davis JW, Dudek J, Eichler BA, Fernandes JC, Fondario A, Gabella B, Hume B, Huntamer T, Kariisa M, Largo TW, Miles J, Newmyer A, Nitcheva D, Perez BE, Proescholdbell SK, Sabel JC, Skiba J, Slavova S, Stone K, Tharp JM, Wendling T, Wright D, Zehner AM; Centers for Disease Control and Prevention (CDC). Increases in heroin overdose deaths-28 States, 2010 to 2012. MMWR 2014 Oct 3;63(39):849-54. Retrieved from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6339a1.htm.
19. Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers-United States, 2002-2004 and 2008-2010. Drug Alcohol Depend 2013;132:95-100.
20. Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry 2014;71:821-6.
21. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Associations of Nonmedical Pain Reliever Use and Initiation of Heroin Use in the United States. August 2013. Retrieved from: http://www.samhsa.gov/data/2k13/DataReview /DR006/nonmedical-pain-reliever-use-2013.pdf.
22. PDMP Training and Technical Assistance Center. PDMP Frequently Asked Questions. Retrieved from: http://www. pdmpassist.org/content/prescription-drug-monitoring-frequent ly-Asked-questions-faq.
23. PDMP Center of Excellence at Brandeis University. Briefing on PDMP Effectiveness: Updated September 2014. Retrieved from: http://www.pdmpexcellence.org/sites/all/pdfs/Briefing%20on%20PDMP%20Effectiveness%203rd%20revision.pdf.
24. Curtis LH, Stoddard J, Radeva JI, Hutchison S, Dans PE, Wright A, et al. Geographic variation in the prescription of schedule II opioid analgesics among outpatients in the United States. Health Serv Res. 2006 2006;41: 837-55.
25. Reifler L, Droz D, Bailey J, Schnoll S, Fant R, Dart R, et al. Do prescription monitoring programs impact state trends in opioid abuse/misuse?. Pain Medicine. 2012;13(3):355-6.
26. Reisman RM, Shenoy PJ, Atherly AJ, Flowers CR. Prescription opioid usage and abuse relationships: an evaluation of state prescription drug monitoring program efficacy. Substance Abuse: Research and Treatment. 2009;3(SART-3-Shenoy-et-Al):41.
27. Worley J. Prescription drug monitoring programs, a response to doctor shopping: purpose, effectiveness, and directions for future research. Issues in Mental Health Nursing, 2012, 33:319-328.
28. Simeone R, Holland L. Washington, D.C.: U.S. Dept. of Justice, Office of Justice Programs 2006. Retrieved from: http://www.simeoneassociates.com/simeone3.pdf.
29. PDMP Center of Excellence at Brandeis University. COE Briefing-Mandating PDMP Participation by Medical Providers: Current Status and Experience in Selected States. Retrieved from: http://www.pdmpexcellence.org/sites/all/pdfs/COE%20briefing%20on%20mandates%20revised a.pdf.
30. Charles K, Cannon M, Hall R, Coustasse A. Can Utilizing a Computerized Provider Order Entry (CPOE) System Prevent Hospital Medical Errors and AdverseDrug Events?. Perspect Health Inf Manag. 2014 Oct 1;11:1b. eCollection 2014.
31. Department of Health and Human Services. Connecting Prescribers and Dispensers to PDMPs through Health IT; 2013. Retrieved from: http://www.healthit.gov/sites/default/files/pdmp pilot studies summary.pdf.
32. Wolfstadt JI, Gurwitz JH, Field TS, Lee M, Kalkar S, Wu W, Rochon PA The effect of computerized physician order entry with clinical decision support on the rates of adverse drug events: a systematic review. J Gen Intern Med. 2008 Apr;23(4):451-8. doi: 10.1007/s11606-008-0504-5.
33. Mishuris RG, Linder JA, Bates DW, Bitton A Using electronic health record clinical decision support is associated with improved quality of care. Am J Manag Care. 2014 Oct 1;20(10):e445-52.
34. PDMP Center of Excellence at Brandeis University. Prescription Drug Monitoring Programs: An Assessment of the Evidence for Best Practices, September 2012. Retrieved from: http://www.pdmpexcellence.org/sites/all/pdfs/Brandeis PDMP Report.pdf.
35. Franklin GM, Mai J, Turner J, Sullivan M, Wickizer T, Fulton-Kehoe D. Bending the prescription opioid dosing and mortality curves: impactof the Washington State opioid dosing guideline. Am J Ind Med. 2012;55(4):325-31.
36. Boyer EW. Management of opioid analgesic overdose. N Engl J Med. 2012;367(2):145-155.
37. Coffin PO, Sullivan SD. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med.2013;158(1):1-9.
38. Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, Ruiz S, Ozonoff A. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013 Jan 30;346:f174. doi: 10.1136/bmj.f174.